Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2400 (LINC02400)

Target
LINC02400
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2400 (LINC02400) is a human gene that encodes a long intergenic non-coding RNA (lincRNA), meaning it produces an RNA molecule greater than 200 nucleotides in length which does not encode a protein[1][5][3]. LINC02400 belongs to the lncRNA/lincRNA class, which broadly function in gene expression regulation, chromatin remodeling, and maintenance of cellular transcriptional states, but to date, there is no published evidence for its specific biological function, disease role, interaction with drugs, or clinical biomarker utility[1][3][5]. Key context: - LINC02400 should not be confused with numerically similar lincRNAs such as LINC00665, which have known functions in cancer[2]. - Unlike some lincRNAs, LINC02400 has not yet been linked to specific cellular pathways, disease states, or drug response[1][5]. - The gene is categorized as a non-protein coding gene and is referenced in genomic databases, but without characterized roles in disease or therapy[1][5].

Other names
LINC02400
02

Mechanism of action

None reported

03

Biological functions

Unknown (no specific biological functions have been characterized or reported in curated sources to date for LINC02400)
04

Disease associations

Unknown (no direct association with specific disease roles has been documented in the available literature; not reported as associated with cancer, inflammation, etc.)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2400 (LINC02400).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2400 (LINC02400).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call